跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARBOCAINE 2% WITH NEO-COBEFRIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CARBOCAINE 2% WITH NEO-COBEFRIN
Authorized
STANDARD
CARBOCAINE 2% WITH NEO-COBEFRIN
novocol pharmaceutical of canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
68516fb60aecb0c5
Company
novocol pharmaceutical of canada inc
Type
Standard
Approval Details
Approval Id
68516fb60aecb0c5
Drug Approval Canada Name
CARBOCAINE 2% WITH NEO-COBEFRIN
Product Name
CARBOCAINE 2% WITH NEO-COBEFRIN
Status
Cancelled Post Market
Status Date
2023-03-20
Original Market Date
2019-07-30
Din
02474182
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Block/Infiltration
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB53 MEPIVACAINE, COMBINATIONS
Atc Name
n 01 bb 53
Aig Number
0248622001
Company Name
novocol pharmaceutical of canada inc
Company Address
25 Wolseley Court, Cambridge, Ontario, Canada, N1R 6X3
Active Ingredients
CORBADRINE
0.05 MG / ML
MEPIVACAINE HYDROCHLORIDE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
68516fb60aecb0c5
Type
Standard
Back to Health Canada Approvals